Latest goodwill for PLYX: $0.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (March 2026), PLYX shows a goodwill of $0. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, PLYX's goodwill is now $0 (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Polaryx Therapeutics Common Stock is outperforming or lagging.
Tracking PLYX's goodwill over time shows whether Polaryx Therapeutics Common Stock is scaling, shrinking, or reshaping that part of the business. The current reading is $0 In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this goodwill page, Stockcircle has Polaryx Therapeutics Common Stock's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect goodwill (currently $0) with ownership activity and broader fundamentals.
Polaryx Therapeutics Common Stock's goodwill is $0; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.